Cryofocus Medtech (Shanghai) Co., Ltd.

SEHK:6922 Stock Report

Market Cap: HK$1.7b

Cryofocus Medtech (Shanghai) Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of 6922?
Owner TypeNumber of SharesOwnership Percentage
Institutions7,337,9923.07%
General Public24,624,04010.3%
Employee Share Scheme25,233,21610.6%
Individual Insiders39,362,14016.5%
VC/PE Firms59,128,55224.7%
Private Companies83,424,06034.9%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 14 shareholders own 89.7% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
32.6%
Ningbo Linfeng Biotechnology Co., Ltd
77,914,668HK$544.6m0%no data
10.6%
Cryofocus Medtech (Shanghai) Co., Ltd., ESOP
25,233,216HK$176.4m0%no data
9.9%
Hangzhou Proxima Innovative Investment Management L.P.
23,660,700HK$165.4m0%no data
9.7%
Shenzhen Gaoling Tiancheng Phase 3 Investment Co., Ltd.
23,184,352HK$162.1m19.9%15.36%
9.15%
Shiwen Lv
21,869,988HK$152.9m0%no data
5.14%
Suzhou Industrial Park Yuanfu Venture Capital Management Enterprise (Limited Partnership)
12,283,500HK$85.9m0%12.05%
3.33%
Qian Zhang
7,963,128HK$55.7m0%no data
3.29%
Jianhui Wu
7,873,000HK$55.0m2.36%no data
2.3%
Ningbo Kangrui Investment Management Partnership (Limited Partnership)
5,509,392HK$38.5m0%no data
2.06%
Fullgoal Fund Management Co. Ltd.
4,918,000HK$34.4m0%0.01%
1.01%
Ningbo Tongshang Fund Management Co., Ltd.
2,419,992HK$16.9m0%no data
0.62%
Jun Zhu
1,472,424HK$10.3m0%no data
0.041%
Hui Li
97,600HK$682.3k13.5%no data
0.036%
Kejian Li
86,000HK$601.2k0%no data